Home Noscendo GmbH

Noscendo GmbH

Noscendo Reaches CE Certification as Key Milestone for its Proprietary Diagnostic Platform DISQVER® and Conducts Successful Piloting in Eight Maximum Care Hospitals

DISQVER® testing has identified pathogens relevant for treatment especially in the case of pathogens that are difficult to cultivate and in the case of patients with prior antibiotic treatment.